U.S. FDA Approves Expanded Label for Astellas' IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAY™ ...
Le Lézard7h
U.S. FDA Approves Expanded Label for Astellas' IZERVAYtm (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S. Prescribing information for IZERVAYtm ...
Medscape5d
Cataract Surgery in Patients With Diabetes and Age-Related Macular Degeneration
This study was limited as patients were not randomized and only eight patients had either geographic atrophy or choroidal neovascularization. When treating cataract with coexisting retinal disease ...
BMJ5d
Vascular flow density in pathological myopia: an optical coherence tomography angiography study
One study showed that in pathologically myopic eyes severe choriocapillaris atrophy was present and the normal anatomic ... Thus the flow density actually measured might include the medium-size ...
pharmaphorum1d
FDA says no to Astellas' geographic atrophy drug
Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US. The company has received a complete response letter (CRL) from the FDA for a ...
Medscape5d
Lactational Atrophic Vaginitis
The management of atrophic vaginitis may include self-help measures, estrogen replacement, and botanical therapies, as well as education. Self-help measures include the use of water-based vaginal ...